Abeona Therapeutics Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-13.0M | $-13.5M | $519.0K | — |
| FY2017 | $-22.7M | $-23.5M | $860.0K | — |
| FY2018 | $-39.1M | $-48.4M | $9.2M | — |
| FY2019 | $-62.8M | $-69.1M | $6.3M | — |
| FY2020 | $-35.0M | $-36.4M | $1.3M | — |
| FY2021 | $-65.7M | $-69.8M | $4.2M | — |
| FY2022 | $-43.5M | $-43.6M | $130.0K | $3.1M |
| FY2023 | $-37.0M | $-37.3M | $331.0K | $4.8M |
| FY2024 | $-56.0M | $-58.5M | $2.4M | $6.6M |
| FY2025 | $-76.3M | $-84.3M | $8.0M | $10.8M |